IMARC Group, a leading market research company, has recently releases report titled “Neurovascular Devices Market Report by Product (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices), Application (Ischemic Stroke, Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Stenosis, and Others), End User (Hospitals, Ambulatory Surgical Centers, Clinics, and Others), and Region 2023-2028.” Offers a comprehensive analysis of the industry, which comprises insights on the market.

How Big is the Neurovascular Devices Market?

The global neurovascular devices market size reached US$ 2.74 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.90 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.

Industry Overview of Neurovascular Devices

Neurovascular devices are medical instruments and tools specifically engineered to diagnose, treat, and manage disorders related to the blood vessels of the nervous system. They comprise catheters, which are crucial for navigating the vascular system during interventions and providing access to targeted areas. They also consist of coils, which are deployed to block blood flow into aneurysms, promoting clotting and preventing rupture. They include clot retravel systems, which are designed to remove blood clots in the cerebral vessels, restoring blood flow and preventing further neurological damage in ischemic stroke cases. They must be biocompatible to minimize the risk of adverse reactions within the delicate neural environment. They also offer excellent navigability to access and treat specific regions with precision. They rely on real-time imaging and are compatible with various imaging modalities to ensure accurate visualization during interventions. Neurovascular devices often incorporate safety features, such as flow diverters and stents, to prevent complications and ensure successful outcomes. They enable minimally invasive procedures, reducing patient recovery times and the overall risk associated with traditional open surgeries. Neurovascular devices used in diagnostic imaging contribute to accurate and timely diagnoses, enabling healthcare professionals to implement targeted treatment strategies. They are used in angiography procedures to visualize blood vessels in the brain and identify abnormalities, such as aneurysms, arteriovenous malformations (AVMs), and stenosis.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/neurovascular-devices-market/requestsample

What are the growth prospects and trends in the neurovascular devices industry?

At present, the increasing advancements in imaging technologies, such as advanced magnetic resonance imaging (MRI) and computed tomography (CT), to enhance the precision and accuracy of neurovascular diagnostics represent one of the crucial factors impelling the growth of the market. Besides this, the rising development of minimally invasive procedures, including endovascular treatments and neuro interventional surgeries, is contributing to the market growth. In addition, the growing occurrence of various neurological disorders, particularly strokes due to lifestyle changes and sedentary habits, is driving the adoption of neurovascular devices, such as stent retrievers, flow diverters, and embolic coils, for effective diagnosis and treatment.

The elderly population is also seeking advanced medical interventions to address neurological issues. Apart from this, public awareness campaigns, advancements in medical education, and the dissemination of information through various media channels are empowering patients to seek timely medical intervention. Stringent regulatory standards and the need for approvals from health authorities influence the development, manufacturing, and commercialization of neurovascular devices. Regulatory compliance also ensures the safety and efficacy of these devices, instilling confidence among healthcare professionals and end-users.

Additionally, the rising improvement in the healthcare infrastructure, along with the construction of various hospitals and nursing homes around the world to provide quality healthcare services to patients, is strengthening the market growth. Moreover, the increasing complexity of developing cutting-edge technologies and navigating stringent regulatory landscapes is encouraging companies to form alliances, fostering innovation, and expediting the introduction of new neurovascular devices. These collaborations also facilitate knowledge exchange and resource pooling, ultimately benefiting patients through improved access to advanced neurointerventional therapies.

Leading Companies Operating in the Global Neurovascular Devices Industry:

• Acandis GmbH
• Asahi Intecc Co. Ltd.
• Imperative Care Inc.
• Integer Holdings Corporation
• Johnson Johnson
• Medtronic plc
• MicroPort Scientific Corporation
• Penumbra Inc.
• Perflow Medical Ltd.
• Rapid Medical
• Stryker Corporation
• Terumo Corporation

   

Neurovascular Devices Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

• Cerebral Embolization and Aneurysm Coiling Devices 
  • Embolic Coils
  • Flow Diverters
  • Liquid Embolic Agents
• Cerebral Angioplasty and Stenting Systems 
  • Carotid Artery Stents
  • Embolic Protection Devices
• Neurothrombectomy Devices 
  • Clot Retrieval Devices
  • Suction Devices
  • Vascular Snares
• Support Devices 
  • Micro Catheters
  • Micro Guidewires

Breakup by Application:

• Ischemic Stroke
• Aneurysm
• Arteriovenous Malformation and Fistulas (AVM)
• Stenosis
• Others

Breakup by End User:

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

Breakup by Region:

• North America: (United States, Canada)

• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America: (Brazil, Mexico, Others)

• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163